Metraipolis › archive › dc_ca16fd8354bc

Mutations that confer resistance to broadly-neutralizing antibodies define HIV-1 variants of transmitting mothers from that of non-transmitting mothers — Europe PMC PMID:33798244

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/33798244
DOI
10.1371/journal.ppat.1009478
License (as archived)
CC0-1.0
Archived
2026-11-05T04:05:00.070Z
SHA-256 of the archived text
d19d2166be5e83072970658b5585753f2eab17dc2f882e3dafc7ae531faa9bd2
Stable URL of this page
https://metraipolis.com/documento/dc_ca16fd8354bc

How to cite

Mutations that confer resistance to broadly-neutralizing antibodies define HIV-1 variants of transmitting mothers from that of non-transmitting mothers — Europe PMC PMID:33798244 — Europe PMC (en), https://europepmc.org/article/MED/33798244 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_ca16fd8354bc (Metraipolis archive dc_ca16fd8354bc, sha256 d19d2166be5e83072970658b5585753f2eab17dc2f882e3dafc7ae531faa9bd2)
BibTeX
@misc{dcca16fd8354bc,
  title = {Mutations that confer resistance to broadly-neutralizing antibodies define HIV-1 variants of transmitting mothers from that of non-transmitting mothers — Europe PMC PMID:33798244},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/33798244},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_ca16fd8354bc; sha256 d19d2166be5e83072970658b5585753f2eab17dc2f882e3dafc7ae531faa9bd2},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/33798244. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Despite considerable reduction of mother-to-child transmission (MTCT) of HIV through use of maternal and infant antiretroviral therapy (ART), over 150,000 infants continue to become infected with HIV annually, falling far short of the World Health Organization goal of reaching <20,000 annual pediatric HIV cases worldwide by 2020. Prior to the widespread use of ART in the setting of pregnancy, over half of infants born to HIV-infected mothers were protected against HIV acquisition. Yet, the role of maternal immune factors in this protection against vertical transmission is still unclear, hampering the development of synergistic strategies to further reduce MTCT. It has been established that infant transmitted/founder (T/F) viruses are often resistant to maternal plasma, yet it is unknown if the neutralization resistance profile of circulating viruses predicts the maternal risk of transmission to her infant. In this study, we amplified HIV-1 envelope genes (env) by single genome amplification and produced representative Env variants from plasma of 19 non-transmitting mothers from the U.S. Women Infant Transmission Study (WITS), enrolled in the pre-ART era. Maternal HIV Env variants from non-transmitting mothers had similar sensitivity to autologous plasma as observed for non-transmitting variants from transmitting mothers. In contrast, infant variants were on average 30% less sensitive to paired plasma neutralization compared to non-transmitted maternal variants from both transmitting and non-transmitting mothers (p = 0.015). Importantly, a signature sequence analysis revealed that motifs enriched in env sequences from transmitting mothers were associated with broadly neutralizing antibody (bnAb) resistance. Altogether, our findings suggest that circulating maternal virus resistance to bnAb-mediated neutralization, but not autologous plasma neutralization, near the time of delivery, predicts increased MTCT risk. These results caution that enhancement of maternal plasma neutralization through passive or active vaccination during pregnancy may potentially drive the evolution of variants fit for vertical transmission.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLoS pathogens, 2021 (prima pubblicazione 2021-04-02).
Identificativi: PMID 33798244 · PMCID PMC8055002 · DOI 10.1371/journal.ppat.1009478.
Descrittori MeSH principali: Genetic Variation; Infectious Disease Transmission, Vertical.
Pagina: https://europepmc.org/article/MED/33798244 — https://doi.org/10.1371/journal.ppat.1009478. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-05T03:58:32.068Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.